Evidence-Based Haemostasis

Disease Transmission by Blood Products - Past, Present and Future, W.G. Murphy; The Evidence behind Inhibitor Treatment with Porcine Factor VIII, C.A. Lee; Evidence for the Use of Activated Prothrombin Complex Concentrates (aPCCs) in the Treatment of Patients with Haemophilia and Inhibitors, J.T. Wilde; The Evidence behind Inhibitor Treatment with Recombinant Factor VIIa, C.A. Ludlam; The 2000 United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO) Inhibitor Guidelines, C.R.M. Hay; Recombinant Factor VIIa in the Management of Surgery and Acute Bleeding Episodes in Children with Haemophilia and High-Responding Inhibitors, O.P. Smith; High Cost Patients and the Consortium Approach, S. Schonfield, K. Reid; Economic Impact of Treating Inhibitor Patients, L. Lacey; General Haemostatic Agents - Fact or Fiction?, U. Hedner; Treatment of Bleeding in Patients with Platelet Disorders - Is There a Place for Recombinant Factor VIIa?, Y. Laurian; The Use of Recombinant Factor VIIa in Controlling Surgical Bleeding in Non-Haemophiliac Patients, M. Aldouri; To General Haemostasis - the Evidence-Based Route, E. Erhardtsen.